Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings

Abstract Positive results from cancer screenings, like a cancer diagnosis, can increase the risk of cardiovascular disease (CVD) mortality due to heightened psychological stress. However, positive screening results may also serve as a teachable moment to encourage the adoption of a healthier lifesty...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuting Ji, Yu Zhang, Hongyuan Duan, Xiaomin Liu, Yunmeng Zhang, Zhuowei Feng, Jingjing Li, Zeyu Fan, Ya Liu, Yacong Zhang, Lei Yang, Zhangyan Lyu, Fangfang Song, Fengju Song, Hua Li, Yubei Huang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-78252-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594739693617152
author Yuting Ji
Yu Zhang
Hongyuan Duan
Xiaomin Liu
Yunmeng Zhang
Zhuowei Feng
Jingjing Li
Zeyu Fan
Ya Liu
Yacong Zhang
Lei Yang
Zhangyan Lyu
Fangfang Song
Fengju Song
Hua Li
Yubei Huang
author_facet Yuting Ji
Yu Zhang
Hongyuan Duan
Xiaomin Liu
Yunmeng Zhang
Zhuowei Feng
Jingjing Li
Zeyu Fan
Ya Liu
Yacong Zhang
Lei Yang
Zhangyan Lyu
Fangfang Song
Fengju Song
Hua Li
Yubei Huang
author_sort Yuting Ji
collection DOAJ
description Abstract Positive results from cancer screenings, like a cancer diagnosis, can increase the risk of cardiovascular disease (CVD) mortality due to heightened psychological stress. However, positive screening results may also serve as a teachable moment to encourage the adoption of a healthier lifestyle. Consequently, the overall association between positive screenings and CVD mortality risk remains unclear. Based on PLCO data, the risk of CVD mortality associated with the number and types of positive screens was evaluated using Cox regression models among 149,258 eligible participants enrolled between 1993 and 2001. Additional analyses explored these associations stratified by prior CVD history. Exploratory analyses were also conducted to investigate whether positive screens were linked to the potential adoption of a healthier lifestyle. After a median follow-up of 19 years, significantly decreased risk of CVD mortality was observed for individuals with occasional positive screening (≤ 2 positive screens) [adjusted hazard ratio (HR, 95%CIs): 0.931 (0.897–0.968), P < 0.001] compared to the control arm. This effect was particularly notable for flexible sigmoidoscopy [0.842 (0.802–0.884), P < 0.001] and transvaginal ultrasound [0.855 (0.776–0.942), P = 0.002]. However, when the number of positive screens increased to more than two, the reduced risk of CVD mortality became non-significant [0.977 (0.941–1.014), P = 0.220]. Subgroup analyses revealed a greater reduction in CVD mortality risk among participants without a history of CVD [0.917 (0.864–0.973)] compared to those with a history of CVD [0.944 (0.898–0.993)]. Sensitivity analyses excluding screening-detected cancers showed similar association in the overall population [0.933 (0.897–0.970)], as well as in both subgroups with [0.945 (0.898–0.995)] and without previous CVD [0.919 (0.865–0.976)]. Exploratory analyses indicated a significantly higher proportion of any body mass index (BMI) reduction among those with a baseline BMI ≥ 25 kg/m2 who had positive screens compared to the control arm, particularly for individuals with occasional positive screens (48.07% vs. 47.04%, P value = 0.037). Occasional positive cancer screening are associated with reduced risk of CVD mortality, regardless of prior CVD history, cancer diagnosis, and other competitive risks.
format Article
id doaj-art-0c731011e49f4b92936963b31ad69466
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-0c731011e49f4b92936963b31ad694662025-01-19T12:20:04ZengNature PortfolioScientific Reports2045-23222025-01-0115111210.1038/s41598-024-78252-2Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screeningsYuting Ji0Yu Zhang1Hongyuan Duan2Xiaomin Liu3Yunmeng Zhang4Zhuowei Feng5Jingjing Li6Zeyu Fan7Ya Liu8Yacong Zhang9Lei Yang10Zhangyan Lyu11Fangfang Song12Fengju Song13Hua Li14Yubei Huang15Department of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & InstituteDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityDepartment of Endoscopy, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and HospitalDepartment of Epidemiology and Biostatistics, Key Laboratory of Molecular Cancer Epidemiology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical UniversityAbstract Positive results from cancer screenings, like a cancer diagnosis, can increase the risk of cardiovascular disease (CVD) mortality due to heightened psychological stress. However, positive screening results may also serve as a teachable moment to encourage the adoption of a healthier lifestyle. Consequently, the overall association between positive screenings and CVD mortality risk remains unclear. Based on PLCO data, the risk of CVD mortality associated with the number and types of positive screens was evaluated using Cox regression models among 149,258 eligible participants enrolled between 1993 and 2001. Additional analyses explored these associations stratified by prior CVD history. Exploratory analyses were also conducted to investigate whether positive screens were linked to the potential adoption of a healthier lifestyle. After a median follow-up of 19 years, significantly decreased risk of CVD mortality was observed for individuals with occasional positive screening (≤ 2 positive screens) [adjusted hazard ratio (HR, 95%CIs): 0.931 (0.897–0.968), P < 0.001] compared to the control arm. This effect was particularly notable for flexible sigmoidoscopy [0.842 (0.802–0.884), P < 0.001] and transvaginal ultrasound [0.855 (0.776–0.942), P = 0.002]. However, when the number of positive screens increased to more than two, the reduced risk of CVD mortality became non-significant [0.977 (0.941–1.014), P = 0.220]. Subgroup analyses revealed a greater reduction in CVD mortality risk among participants without a history of CVD [0.917 (0.864–0.973)] compared to those with a history of CVD [0.944 (0.898–0.993)]. Sensitivity analyses excluding screening-detected cancers showed similar association in the overall population [0.933 (0.897–0.970)], as well as in both subgroups with [0.945 (0.898–0.995)] and without previous CVD [0.919 (0.865–0.976)]. Exploratory analyses indicated a significantly higher proportion of any body mass index (BMI) reduction among those with a baseline BMI ≥ 25 kg/m2 who had positive screens compared to the control arm, particularly for individuals with occasional positive screens (48.07% vs. 47.04%, P value = 0.037). Occasional positive cancer screening are associated with reduced risk of CVD mortality, regardless of prior CVD history, cancer diagnosis, and other competitive risks.https://doi.org/10.1038/s41598-024-78252-2Cardiovascular diseaseDeathCancerPositive screenCox regression modelCohort
spellingShingle Yuting Ji
Yu Zhang
Hongyuan Duan
Xiaomin Liu
Yunmeng Zhang
Zhuowei Feng
Jingjing Li
Zeyu Fan
Ya Liu
Yacong Zhang
Lei Yang
Zhangyan Lyu
Fangfang Song
Fengju Song
Hua Li
Yubei Huang
Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
Scientific Reports
Cardiovascular disease
Death
Cancer
Positive screen
Cox regression model
Cohort
title Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
title_full Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
title_fullStr Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
title_full_unstemmed Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
title_short Decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
title_sort decreased risk of cardiovascular disease mortality associated with occasional positive screens following cancer screenings
topic Cardiovascular disease
Death
Cancer
Positive screen
Cox regression model
Cohort
url https://doi.org/10.1038/s41598-024-78252-2
work_keys_str_mv AT yutingji decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT yuzhang decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT hongyuanduan decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT xiaominliu decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT yunmengzhang decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT zhuoweifeng decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT jingjingli decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT zeyufan decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT yaliu decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT yacongzhang decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT leiyang decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT zhangyanlyu decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT fangfangsong decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT fengjusong decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT huali decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings
AT yubeihuang decreasedriskofcardiovasculardiseasemortalityassociatedwithoccasionalpositivescreensfollowingcancerscreenings